Thomas Beetham
2021 - Dianthus Therapeutics
In 2021, Thomas Beetham earned a total compensation of $1.9M as Chief Legal Officer at Dianthus Therapeutics.
Compensation breakdown
| Non-Equity Incentive Plan | $92,000 |
|---|---|
| Option Awards | $1,567,779 |
| Salary | $230,681 |
| Other | $3,920 |
| Total | $1,894,380 |
Beetham received $1.6M in option awards, accounting for 83% of the total pay in 2021.
Beetham also received $92K in non-equity incentive plan, $230.7K in salary and $3.9K in other compensation.
Rankings
In 2021, Thomas Beetham's compensation ranked 6,248th out of 12,406 executives tracked by ExecPay. In other words, Beetham earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,248 out of 12,406 | 50th |
Division Manufacturing | 2,649 out of 5,494 | 52nd |
Major group Chemicals And Allied Products | 1,159 out of 2,369 | 51st |
Industry group Drugs | 1,031 out of 2,090 | 51st |
Industry Pharmaceutical Preparations | 746 out of 1,537 | 52nd |
Source: SEC filing on May 2, 2022.
Beetham's colleagues
We found two more compensation records of executives who worked with Thomas Beetham at Dianthus Therapeutics in 2021.